Ads
related to: docusate 100mg capsules side effects treatment chart for women- Side Effects
Learn About Common Side Effects And
What To Do If They Occur.
- Food and Diet Tips
Get Diet Tips and Recipes to Manage
Your Symptoms.
- Check Your Symptoms
Take A 5-Question Quiz To Learn
More About Your IBS-C Symptoms
- FAQs
Read Through Commonly Asked
Questions About IBS-C/CIC.
- Free Digital Cookbook
Prepare Tasty Gut-Friendly Meals
With A Free Digital Cookbook.
- IBS-C/CIC Tips & Support
Sign Up To Receive Treatment
and IBS-C/CIC Management Tips.
- Side Effects
Search results
Results From The WOW.Com Content Network
Docusate is the common chemical and pharmaceutical name of the anion bis(2-ethylhexyl) sulfosuccinate, also commonly called dioctyl sulfosuccinate (DOSS). [ 2 ] [ 3 ] [ 4 ] Salts of this anion, especially docusate sodium , are widely used in medicine as an emollient laxative and as stool softeners , by mouth or rectally. [ 1 ]
A 2018 pooled analysis from three phase III, randomized, double-blind, placebo-controlled studies on usage for Opioid-Induced Constipation, found that the numbers of patients reporting adverse effects were similar in both the lubiprostone and placebo treatment groups for all opioid classes (P ≥ 0.125); however, gastrointestinal adverse ...
Dosage Fforms Strengths Brand names Manufacturer Oral: Capsules, extended-release: 150 mg (50 mg iron) with Docusate Sodium 100 mg* Ferrous Fumarate with DSS® Timed Capsules: Vita-Rx Tablets, extended-release, film-coated: 150 mg (50 mg iron) with Docusate Sodium 100 mg: Ferro-DSS® Caplets® Time-Caps Ferro-Sequels® Inverness
Calcium dobesilate is a vasoprotective.It is the calcium salt of dobesilic acid.It is a synthetic molecule with the ability to reduce capillary permeability in the body. In Switzerland the drug is sold by the pharmaceutical company OM Pharma under the trade name of Doxium in capsules containing 500 mg of active ingredient.
Miglustat is indicated to treat adults with mild to moderate type I Gaucher disease for whom enzyme replacement therapy is unsuitable. [14]In the European Union, miglustat (Opfolda), in combination with cipaglucosidase alfa, is a long-term enzyme replacement therapy in adults with late-onset Pompe disease (acid α‑glucosidase [GAA] deficiency).
Side effects of doxylamine include dizziness, drowsiness, and dry mouth, among others. [4] Doxylamine is a potent anticholinergic and has a side-effect profile common to such drugs, including blurred vision , dry mouth, constipation , muscle incoordination , urinary retention , mental confusion , and delirium .